World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
86
Citations
25653
World Ranking
1270
National Ranking
83

Medicine

D-Index
86
Citations
25689
World Ranking
14188
National Ranking
752

Christoph Loddenkemper publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Christoph Loddenkemper sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 331 publications — 70th percentile

70% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Christoph Loddenkemper D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Christoph Loddenkemper sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 86 D-Index — 75th percentile

75% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Christoph Loddenkemper is affiliated with Charité - University Medicine Berlin in Germany. Their research primarily spans the field of Medicine, with a focus on subfields such as Epidemiology, Gastroenterology, Infectious Diseases, Immunology, and Surgery.

The main topics addressed in Loddenkemper's work include:

  • Celiac Disease Research and Management
  • Microscopic Colitis
  • Liver Disease Diagnosis and Treatment
  • COVID-19 Clinical Research Studies
  • Immune Cell Function and Interaction
  • Gastrointestinal disorders and treatments
  • Diet, Metabolism, and Disease

The scientist has published across several academic venues, with frequent contributions to the following journals:

  • Zeitschrift für Gastroenterologie
  • The Lancet Infectious Diseases
  • Mucosal Immunology
  • Gut
  • Acta Biomaterialia

Among the notable recent papers associated with Christoph Loddenkemper are:

  • Human small intestinal infection by SARS-CoV-2 is characterized by a mucosal infiltration with activated CD8+ T cells, 2021, Mucosal Immunology
  • Aktualisierte S2k-Leitlinie Zöliakie der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS), 2022, Zeitschrift für Gastroenterologie
  • Prospective, double-blind diagnostic multicentre study of confocal laser endomicroscopy for wheat sensitivity in patients with irritable bowel syndrome, 2021, Gut
  • Treatment of disseminated nocardiosis: a host-pathogen approach with adjuvant interferon gamma, 2021, The Lancet Infectious Diseases
  • How histopathologic changes in pediatric nonalcoholic fatty liver disease influence in vivo liver stiffness, 2021, Acta Biomaterialia

Loddenkemper frequently collaborates with several co-authors, including:

  • Michael Schümann
  • Thomas Schneider
  • Britta Siegmund
  • Christian Bojarski
  • Verena Moos

Best Publications

  • Oncogene-induced senescence as an initial barrier in lymphoma development

    Melanie Braig;Soyoung Lee;Christoph Loddenkemper;Cornelia Rudolph

  • Selective depletion of Foxp3+ regulatory T cells induces a scurfy-like disease.

    Katharina Lahl;Christoph Loddenkemper;Cathy Drouin;Jennifer Freyer

  • Evidence for the cure of HIV infection by CCR5Δ32/Δ32 stem cell transplantation.

    Kristina Allers;Gero Hütter;Jörg Hofmann;Christoph Loddenkemper

  • Peripheral and intestinal regulatory CD4+CD25high T cells in inflammatory bowel disease

    Jochen Maul;Christoph Loddenkemper;Pamela Mundt;Erika Berg

  • A guide to histomorphological evaluation of intestinal inflammation in mouse models

    Ulrike Erben;Christoph Loddenkemper;Katja Doerfel;Simone Spieckermann

  • Whipple's Disease: New Aspects of Pathogenesis and Treatment

    Thomas Schneider;Verena Moos;Christoph Loddenkemper;Thomas Marth

  • Analysis of IL-17+ cells in facet joints of patients with spondyloarthritis suggests that the innate immune pathway might be of greater relevance than the Th17-mediated adaptive immune response

    Heiner Appel;René Maier;Peihua Wu;Rebecca Scheer

  • Prognostic Value of Ki-67 Index, Cytology, and Growth Pattern in Mantle-Cell Lymphoma: Results From Randomized Trials of the European Mantle Cell Lymphoma Network

    Eva Hoster;Andreas Rosenwald;Françoise Berger;Heinz-Wolfram Bernd

  • The microRNA miR-182 is induced by IL-2 and promotes clonal expansion of activated helper T lymphocytes

    Anna-Barbara Stittrich;Claudia Haftmann;Evridiki Sgouroudis;Anja Andrea Kühl

  • Quantitative DNA Methylation Analysis of FOXP3 as a New Method for Counting Regulatory T Cells in Peripheral Blood and Solid Tissue

    Georg Wieczorek;Anne Asemissen;Fabian Model;Ivana Turbachova

  • Anti-inflammatory effects of resveratrol, curcumin and simvastatin in acute small intestinal inflammation

    Stefan Bereswill;Melba Muñoz;André Fischer;Rita Plickert

  • Signaling via the MyD88 Adaptor Protein in B Cells Suppresses Protective Immunity during Salmonella typhimurium Infection

    Patricia Neves;Vicky Lampropoulou;Elisabeth Calderon-Gomez;Toralf Roch

  • Interleukin (IL)-23 mediates Toxoplasma gondii-induced immunopathology in the gut via matrixmetalloproteinase-2 and IL-22 but independent of IL-17.

    Melba Muñoz;Markus M. Heimesaat;Kerstin Danker;Daniela Struck

  • Tumor-infiltrating macrophages and dendritic cells in human colorectal cancer: relation to local regulatory T cells, systemic T-cell response against tumor-associated antigens and survival

    Dirk Nagorsen;Sabine Voigt;Erika Berg;Harald Stein

  • Ki-67 predicts outcome in advanced-stage mantle cell lymphoma patients treated with anti-CD20 immunochemotherapy: results from randomized trials of the European MCL Network and the German Low Grade Lymphoma Study Group.

    Olaf Determann;Eva Hoster;German Ott;German Ott;Heinz Wolfram Bernd

  • Mucosal FOXP3+ regulatory T cells are numerically deficient in acute and chronic GvHD.

    Kathrin Rieger;Christoph Loddenkemper;Christoph Loddenkemper;Jochem Maul;Jochem Maul;Thomas Fietz;Thomas Fietz

  • Selective depletion of Foxp3+ regulatory T cells improves effective therapeutic vaccination against established melanoma.

    Katjana Klages;Christian T. Mayer;Katharina Lahl;Christoph Loddenkemper

  • A helminth immunomodulator reduces allergic and inflammatory responses by induction of IL-10-producing macrophages.

    Corinna Schnoeller;Sebastian Rausch;Smitha Pillai;Angela Avagyan

  • Novel Murine Infection Models Provide Deep Insights into the “Ménage à Trois” of Campylobacter jejuni, Microbiota and Host Innate Immunity

    Stefan Bereswill;André Fischer;Rita Plickert;Lea-Maxie Haag

  • Viscoelasticity-based staging of hepatic fibrosis with multifrequency MR elastography.

    Patrick Asbach;Dieter Klatt;Beate Schlosser;Michael Biermer

Frequent Co-Authors

Martin Zeitz
Martin Zeitz Charité - University Medicine Berlin
Anja A. Kühl
Anja A. Kühl Humboldt-Universität zu Berlin
Harald Stein
Harald Stein Charité - University Medicine Berlin
Eckhard Thiel
Eckhard Thiel Charité - University Medicine Berlin
Britta Siegmund
Britta Siegmund Humboldt-Universität zu Berlin
Markus M. Heimesaat
Markus M. Heimesaat Charité - University Medicine Berlin
Thomas Blankenstein
Thomas Blankenstein Max Delbrück Center for Molecular Medicine
Bernd Dörken
Bernd Dörken Charité - University Medicine Berlin
Jochen Huehn
Jochen Huehn Helmholtz Centre for Infection Research
Stefan Bereswill
Stefan Bereswill Charité - University Medicine Berlin

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in immunology, many find complementing their expertise with nursing specializations rewarding. Pursuing online degrees like a Psychiatric-Mental Health Nurse Practitioner (PMHNP) is accessible through the cheapest pmhnp programs. These programs can enhance skills in patient care by integrating mental health knowledge with immunological concepts.

Advanced nursing degrees such as a Doctor of Nursing Practice (DNP) open doors to leadership roles and specialized practice areas. When considering such degrees, it’s helpful to review the dnp salary to understand the financial benefits across different states.

If you’re looking to shift your clinical focus, exploring acute care nurse practitioner programs can be a great pathway. These programs enable family nurse practitioners to transition into acute care, bridging immunology with direct patient interventions in critical care settings.

Additionally, accelerated nurse practitioner program options provide a faster route for those holding a bachelor’s degree to enter the NP workforce, allowing integration of immunological expertise in diverse clinical roles.

Best Scientists Citing Christoph Loddenkemper

Trending Scientists

Recently Published Articles